Cipro
Company: Bayer
Approval Status: Approved June 1997
Treatment for: acute sinusitis
Areas: Pulmonary/Respiratory Diseases
Possible similar drugs: Cipro; Cipro
General Information
Other Useful Resources
Bayer received approval to market Cipro for acute sinusitis. Cipro’s indications already include the treatment for a wide variety of infectious diseases in adults including lower respiratory infections, urinary tract infections, chronic bacterial prostatis, intra-abdominal infections (with metronidazole), bone and joint infections, and skin and skin structure infections.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
